PHARMACOKINETICS OF AMSACRINE IN PATIENTS RECEIVING COMBINED CHEMOTHERAPY FOR TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA

被引：19
|
作者：
JURLINA, JL
VARCOE, AR
PAXTON, JW
机构：
[1] UNIV AUCKLAND,SCH MED,DEPT PHARMACOL & CLIN PHARMACOL,AUCKLAND,NEW ZEALAND
[2] AUCKLAND HOSP,DEPT HAEMATOL,AUCKLAND,NEW ZEALAND
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1985年 / 14卷 / 01期
关键词：
D O I：
10.1007/BF00552719
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：21 / 25
页数：5
相关论文
共 50 条
  • [31] PROGNOSIS OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA PRECEDED BY A PRELEUKEMIA SYNDROME COMPARED TO PATIENTS WITH DENOVO ACUTE MYELOGENOUS LEUKEMIA WHEN TREATED WITH INTENSIVE CHEMOTHERAPY
    GAJEWSKI, JL
    HO, WG
    HIRJI, KF
    NIMER, SD
    GALE, RP
    CHAMPLIN, RE
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 476 - 476
  • [32] The pharmacokinetics of azacitidine following subcutaneous treatment in patients with myelodysplastic syndromes (MDS) or acute myelogenous leukemia (AML)
    Laille, E.
    Ward, R.
    Nasser, A.
    Stoltz, M.
    Cogle, C.
    Gore, S.
    Skikne, B. S.
    Garcia-Manero, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Homoharringtonine, cytarabine and cyclopbosphamide in patients with acute myelogenous leukemia for induction chemotherapy
    Qiao, ZH
    Su, LP
    Jia, HF
    Liu, GJ
    Pei, YH
    BLOOD, 2002, 100 (11) : 259B - 259B
  • [34] EFFECT OF CHEMOTHERAPY ON ACUTE MYELOGENOUS LEUKEMIA IN CHILDREN
    FREEDMAN, MH
    FINKLESTEIN, JZ
    HAMMOND, GD
    KARON, M
    JOURNAL OF PEDIATRICS, 1971, 78 (03): : 526 - +
  • [35] Serum levels of angiogenin, basic fibroblast growth factor and endostatin in patients receiving intensive chemotherapy for acute myelogenous leukemia
    Glenjen, N
    Mosevoll, KA
    Bruserud, O
    INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (01) : 86 - 94
  • [36] AN INVITRO MODEL FOR ACUTE MYELOGENOUS LEUKEMIA CHEMOTHERAPY
    KOEFFLER, HP
    YEN, J
    LOWE, L
    CANCER, 1981, 48 (09) : 1958 - 1963
  • [37] Initiation of venovenous extracorporeal membrane oxygenation in a patient receiving induction chemotherapy for acute myelogenous leukemia
    Avasarala, Sameer K.
    Qureshi, Muhammad R.
    Waldron, Madeline
    Mukherjee, Sudipto
    Reddy, Anita J.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (06) : 1491 - 1496
  • [38] The Feasibility of Inpatient Geriatric Assessment for Older Adults Receiving Induction Chemotherapy for Acute Myelogenous Leukemia
    Klepin, Heidi D.
    Geiger, Ann M.
    Tooze, Janet A.
    Kritchevsky, Stephen B.
    Williamson, Jeff D.
    Ellis, Leslie R.
    Levitan, Denise
    Pardee, Timothy S.
    Isom, Scott
    Powell, Bayard L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (10) : 1837 - 1846
  • [39] Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia
    Klepin, Heidi D.
    Geiger, Ann M.
    Tooze, Janet A.
    Kritchevsky, Stephen B.
    Williamson, Jeff D.
    Pardee, Timothy S.
    Ellis, Leslie R.
    Powell, Bayard L.
    BLOOD, 2013, 121 (21) : 4287 - 4294
  • [40] ZYGOMYCOSIS DUE TO MUCOR-CIRCINELLOIDES IN A NEUTROPENIC PATIENT RECEIVING CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA
    FINGEROTH, JD
    ROTH, RS
    TALCOTT, JA
    RINALDI, MG
    CLINICAL INFECTIOUS DISEASES, 1994, 19 (01) : 135 - 137
12345